arrow
D

David P. Humphreys

ucb pharma sa
H指数:26
被引数:2,118

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies

抗体Fc段工程对转化药理学及安全性的影响:来自工业案例研究的见解

mAbs
IF7.3
2025-07-070
OAAI
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro

抗FcRn单克隆抗体rozanolixizumab与fc γ 受体的相互作用及其对免疫细胞的功能影响

MABS
IF7.3
2024-01-191
OAAI
Antibodies as drugs-a Keystone Symposia report
2022-11-163
OA
Microbial protein cell factories fight back?
2022-05-0128
OA
Engineered hexavalent Fc proteins with enhanced Fc-gamma receptor avidity provide insights into immune-complex interactions
2018-09-1429
OAAI
Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions
2017-12-0644
OAAI
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding
MABS
IF7.3
2016-08-1743
OAAI